Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis-Reference-Cited by-同舟云学术

Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis

Published:2017-04-10 Issue:7 Volume:38 Page:1213-1221
ISSN:1590-1874
Container-title:Neurological Sciences
language:en
Short-container-title:Neurol Sci

Author:

Casanova Bonaventura,Jarque Isidro,Gascón Francisco,Hernández-Boluda Juan Carlos,Pérez-Miralles Francisco,de la Rubia Javier,Alcalá Carmen,Sanz Jaime,Mallada Javier,Cervelló Angeles,Navarré Arantxa,Carcelén-Gadea María,Boscá Isabel,Gil-Perotin Sara,Solano Carlos,Sanz Miguel Angel,Coret Francisco

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Neurology (clinical),Dermatology,General Medicine

Link

http://link.springer.com/article/10.1007/s10072-017-2933-6/fulltext.html

Reference32 articles.

1. Kutzelnigg A, Lassmann H (2014) Pathology of multiple sclerosis and related inflammatory demyelinating diseases. Handb Clin Neurol 122:15–58

2. Freedman MS (2014) Treatment options for patients with multiple sclerosis who have a suboptimal response to interferon-β therapy. Eur J Neurol 21:377–387

3. Freedman MS, Cohen JA (2011) Meta-analysis of bone marrow transplantation treatment studies: mixing “apples and oranges”. Mult Scler 17:131–132

4. Saccardi R, Freedman MS, Sormani MP et al (2012) A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper. Mult Scler 18:825–834

5. Fassas A, Anagnostopoulos A, Kazis A et al (2000) Autologous stem cell transplantation in progressive multiple sclerosis—an interim analysis of efficacy. J Clin Immunol 20:24–30

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BEAM or cyclophosphamide in autologous haematopoietic stem cell transplantation for relapsing-remitting multiple sclerosis;Bone Marrow Transplantation;2024-08-26

2. Exploring the therapeutic potential of autologous hematopoietic stem cell transplantation in progressive multiple sclerosis—a systematic review;European Journal of Neurology;2024-08-05

3. Efficacy and safety of stem cell transplantation for multiple sclerosis: a systematic review and meta-analysis of randomized controlled trials;Scientific Reports;2024-05-31

4. Stem cell therapies: a new era in the treatment of multiple sclerosis;Frontiers in Neurology;2024-05-09

5. Benefits of aHSCT over alemtuzumab in patients with multiple sclerosis besides disability and relapses: Sustained improvement in cognition and quality of life;Multiple Sclerosis and Related Disorders;2024-02